Status:
COMPLETED
Videoscope-assisted Lateral Maxillary Sinus Floor Elevation: Evaluation of the Schneiderian Membrane for Micro-tears
Lead Sponsor:
University of Manitoba
Conditions:
Videoscope
Maxillary Sinus
Eligibility:
All Genders
18+ years
Brief Summary
This case series will recruit patients who require lateral maxillary sinus floor elevation surgery. This procedure will be carried out as per standard surgical protocol. The periodontal resident perfo...
Eligibility Criteria
Inclusion
- Patients requiring maxillary sinus floor elevation (lateral approach), with current subantral bone height 6 mm or less
- Male or female patient, 18 years of age and older
- Patients who exhibit adequate ability to comply with postoperative instructions, research protocols and methods
- Patients who have read, understand, and have signed the informed consent form
- Patients with an adequate level of oral hygiene, defined as Full Mouth Plaque Score (FMPS) and Full Mouth Bleeding Score (FMBS) should be \<20% (after periodontal therapy, if necessary)
Exclusion
- Absolute contraindications:
- Patients on IV bisphosphonates
- Patients who are undergoing chemotherapy
- Patients who have undergone head and neck radiotherapy where the field of irradiation included the maxilla
- Patients whose membrane thickness is increased due to an existing sinus pathology (sinusitis or mucosal cysts): These conditions should be treated prior to surgical treatment (S. W. Kim et al. 2019)
- Diabetic patients with uncontrolled diabetes and poor glycemic control
- Patients who are undergoing long-term immunosuppressive therapy, or have been taking corticosteroids long-term (Bornstein et al. 2009)
- Patients with active or untreated periodontitis
- Relative contraindications:
- Patients who have been receiving long term oral bisphosphonate therapy (3 years duration or more) (Bornstein et al. 2009)
- Patients who smoke \>10 cigarettes per day
- Patients who are alcohol abusers (Li and Wang 2008)
- Patients who are on antithrombotic medications should be treated with extra caution during surgery, as well as patients with blood disorders that may affect hemostasis
Key Trial Info
Start Date :
November 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 1 2022
Estimated Enrollment :
8 Patients enrolled
Trial Details
Trial ID
NCT04510701
Start Date
November 1 2020
End Date
January 1 2022
Last Update
January 6 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Manitoba
Winnipeg, Manitoba, Canada